ADDED
The number of outstanding shares of the registrant s common stock as of January 28, 2026, was 355,130,237 .
Statements using words such as estimates, projects, believes, anticipates, plans, expects, intends, may, will, could, commit, ensure, promote, should, would, goals, seek, potential, targeted, and similar words and expressions are intended to identify forward-looking statements.
Food and Drug Administration ( FDA ), comparable regulatory authorities, or notified bodies; the risk of our inability to comply with complex FDA and other regulations, which may result in significant enforcement actions; regulatory approvals, clearances, certifications, and restrictions or any dispute that may occur with any regulatory body; healthcare reform legislation in the U.S.
on imports from various countries, including Mexico, where we currently manufacture a significant majority of our instruments and accessories, Germany, where we currently manufacture a majority of our endoscopes, and China, where we currently import certain materials); and other risks and uncertainties, including those listed under the caption Risk Factors.
We are subject to litigation, investigations, and other legal proceedings relating to our products, customers, competitors, and government regulators that may adversely affect our business, financial condition, or results of operations.
Our business is subject to complex and evolving laws and regulations regarding data privacy, data protection, artificial intelligence, and responsible use of data, and any failure to comply may result in significant liability, negative publicity, and/or erosion of trust, which may adversely affect our business, financial condition, or results of operations.
Disruptions at the FDA and other government agencies or notified bodies could prevent our products from being cleared, certified, approved, or commercialized in a timely manner or at all, or could hinder their ability to procure our products, which may adversely affect our business, financial condition, or results of operations.
Changes in tax laws or exposure to additional tax liabilities may adversely affect our business, financial condition, or results of operations.
Product and brand names and logos, including Intuitive, da Vinci, and Ion, are trademarks or registered trademarks of Intuitive Surgical, Inc.
Additional information about our trademarks can be found on our website at www.intuitive.com/trademarks.
REMOVED
The number of outstanding shares of the registrant s common stock as of January 27, 2025, was 356,656,964 .
Statements using words such as estimates, projects, believes, anticipates, plans, expects, intends, may, will, could, should, would, targeted, and similar words and expressions are intended to identify forward-looking statements.
presidential administration on imports from Mexico, where we currently manufacture a significant majority of our instruments and accessories); and other risks and uncertainties, including those listed under the caption Risk Factors.
We are subject to litigation, investigations, and other legal proceedings relating to our products, customers, competitors, and government regulators that could materially adversely affect our financial condition, divert management s attention, and harm our business.
Our business is subject to complex and evolving laws and regulations regarding data privacy, data protection, artificial intelligence, and responsible use of data.
Disruptions at the FDA and other government agencies or notified bodies could hinder their ability to hire, retain, or deploy personnel, or otherwise prevent products from being developed, cleared, certified, approved, or commercialized in a timely manner or at all, which may adversely affect our business, financial condition, or results of operations.
We may incur losses associated with currency fluctuations and may not be able to effectively hedge our exposure.
Changes in our effective tax rate may adversely affect our business, financial condition, or results of operations.
Intuitive , Intuitive Surgical , da Vinci , da Vinci S , da Vinci Si , da Vinci X , da Vinci Xi , da Vinci 5 , da Vinci SP , EndoWrist , Firefly , Flexision , Intuitive 3D Models , Intuitive Hub , Ion , My Intuitive , OnSite , SimNow , SureForm , and SynchroSeal are trademarks or registered trademarks of the Company.
Starting foremost with a focus on patients, we seek to demonstrate that our products can deliver better outcomes that are validated by rigorous peer-reviewed evidence.